Discovery and Preclinical Development of Orally Active Small Molecules that Exhibit Highly Selective Follicle Stimulating Hormone Receptor Agonism

An orally active follicle stimulating hormone receptor allosteric agonist would provide a preferred treatment for over 16 million infertile women of reproductive age in low complexity methods (ovulation induction-intrauterine insemination) or in high complexity methods (controlled ovarian stimulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nataraja, Selva, Yu, Henry, Guner, Joie, Palmer, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845544/
https://www.ncbi.nlm.nih.gov/pubmed/33519465
http://dx.doi.org/10.3389/fphar.2020.602593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845544/
https://www.ncbi.nlm.nih.gov/pubmed/33519465
http://dx.doi.org/10.3389/fphar.2020.602593

Ejemplares similares